Your browser doesn't support javascript.
loading
PBPK model reporting template for chemical risk assessment applications.
Tan, Yu-Mei; Chan, Melissa; Chukwudebe, Amechi; Domoradzki, Jeanne; Fisher, Jeffrey; Hack, C Eric; Hinderliter, Paul; Hirasawa, Kota; Leonard, Jeremy; Lumen, Annie; Paini, Alicia; Qian, Hua; Ruiz, Patricia; Wambaugh, John; Zhang, Fagen; Embry, Michelle.
Afiliação
  • Tan YM; U.S. Environmental Protection Agency, Office of Pesticide Programs, Health Effects Division, 109 TW Alexander Dr, Research Triangle Park, NC, 27709, USA. Electronic address: tan.cecilia@epa.gov.
  • Chan M; Corteva Agriscience, Haskell R&D Center, 1090 Elkton Road, Newark, DE, 19714, USA. Electronic address: melissa.chan@corteva.com.
  • Chukwudebe A; BASF Corporation, 26 Davis Drive, Research Triangle Park, NC, 27709, USA. Electronic address: amechi.chukwudebe@basf.com.
  • Domoradzki J; Corteva Agriscience, Haskell R&D Center, 1090 Elkton Road, Newark, DE, 19714, USA.
  • Fisher J; National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. Electronic address: Jeffrey.Fisher@fda.hhs.gov.
  • Hack CE; ScitoVation, 100 Capitola Drive, Durham, NC, 27713, USA. Electronic address: ehack@scitovation.com.
  • Hinderliter P; Syngenta Crop Protection, LLC, 410 Swing Rd, Greensboro, NC, 27409, USA. Electronic address: paul.hinderliter@alexion.com.
  • Hirasawa K; Sumitomo Chemical Co, Ltd, 1-98, Kasugadenaka 3-chome, Konohana-ku, Osaka, 554-8558, Japan. Electronic address: hirasawak@sc.sumitomo-chem.co.jp.
  • Leonard J; Oak Ridge Institute for Science and Education, 100 ORAU Way, Oak Ridge, TN, 37830, USA. Electronic address: Leonard.Jeremy@epa.gov.
  • Lumen A; National Center for Toxicological Research, US Food and Drug Administration, 3900 NCTR Rd, Jefferson, AR, 72079, USA. Electronic address: Annie.Lumen@fda.hhs.gov.
  • Paini A; European Commission Joint Research Centre, Via E. Fermi 2749, Ispra I, 21027, Italy. Electronic address: alicia.paini@ec.europa.eu.
  • Qian H; ExxonMobil Biomedical Sciences, Inc, 1545 US Hwy 22 East, Annandale, NJ, 08801, USA. Electronic address: hua.qian@exxonmobil.com.
  • Ruiz P; CDC-ATSDR, 4770 Buford Hwy, Mailstop S102-1, Chamblee, GA, 3034, USA. Electronic address: pruiz@cdc.gov.
  • Wambaugh J; US Environmental Protection Agency, Center for Computational Toxicology and Exposure, 109 TW Alexander Dr, Research Triangle Park, NC, 27711, USA. Electronic address: wambaugh.john@epa.gov.
  • Zhang F; The Dow Chemical Company, 1803 Building, Midland, MI, 48674, USA. Electronic address: FZZhang@dow.com.
  • Embry M; Health and Environmental Sciences Institute, 740 15th Street, NW, Suite 600, Washington, DC, 20005, USA. Electronic address: membry@hesiglobal.org.
Regul Toxicol Pharmacol ; 115: 104691, 2020 Aug.
Article em En | MEDLINE | ID: mdl-32502513
ABSTRACT
Physiologically-based pharmacokinetic (PBPK) modeling analysis does not stand on its own for regulatory purposes but is a robust tool to support drug/chemical safety assessment. While the development of PBPK models have grown steadily since their emergence, only a handful of models have been accepted to support regulatory purposes due to obstacles such as the lack of a standardized template for reporting PBPK analysis. Here, we expand the existing guidances designed for pharmaceutical applications by recommending additional elements that are relevant to environmental chemicals. This harmonized reporting template can be adopted and customized by public health agencies receiving PBPK model submission, and it can also serve as general guidance for submitting PBPK-related studies for publication in journals or other modeling sharing purposes. The current effort represents one of several ongoing collaborations among the PBPK modeling and risk assessment communities to promote, when appropriate, incorporating PBPK modeling to characterize the influence of pharmacokinetics on safety decisions made by regulatory agencies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacocinética / Medição de Risco / Modelos Biológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacocinética / Medição de Risco / Modelos Biológicos Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article